Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782442 · ClinicalTrials.gov registry record · NA
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT02782442: Completed NA study, sponsored by University of Minnesota.
NCT02782442 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02782442, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
Primary study: This study is a single-site, double-blind, randomized, controlled clinical trial to compare an evidence-based structured program of 30-35 hours of on-line cognitive and social cognitive training exercises performed over 16 weeks (\~2 hours per week), delivered with an innovative digital app which provides users with a motivation coach to set personalized goals and with secure social networking for peer support, "PRIME" ; vs. 2) A control condition of computer games, encouraged at \~2 hours per week over 16 weeks, delivered with "PRIME". Unblinded Cognitive Training Sub-Study: Participants who were randomized to the computer games arm of the trial may be offered access to the active cognitive training at the end of their 6 month follow up appointments, if they still meet inclusion criteria. PRIME Super Users Sub-Study: Participants who have provided all follow up data to the initial study, including those who are currently enrolled in the Unblinded Cognitive Training sub-study, may be offered continued participation in the PRIME community as super-users.
Primary Outcome
A series of computerized tests administered remotely that measure performance accuracy and speed on specific neurocognitive domains
Interventions
- BEHAVIORAL Structured Cognitive Training & PRIME
- BEHAVIORAL Computer Games Control & PRIME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2022-03-12 |
| Phase | NA |
What the finished NCT02782442 record still lists
NCT02782442 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Structured Cognitive Training & PRIME is the first listed.
NCT02782442 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02782442 about?
NCT02782442 is a clinical study titled "Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)". Primary study: This study is a single-site, double-blind, randomized, controlled clinical trial to compare an evidence-based structured program of 30-35 hours of on-line cognitive and social cognitive training exercises performed over 16 weeks (\~2 hours per week), delivered with an innovative digi...
What is the current status of trial NCT02782442?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2016-09-01. Estimated completion is 2022-03-12.
What interventions are being tested in trial NCT02782442?
The interventions under investigation include: Structured Cognitive Training & PRIME (BEHAVIORAL), Computer Games Control & PRIME (BEHAVIORAL).
Who is sponsoring clinical trial NCT02782442?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02782442's enrollment target sits among peer trials
109 825th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI